By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Adocia 

115 avenue Lacassagne

Lyon    69003  France
Phone: +33-(0)4-72-610-610 Fax: +33-(0)4-72-363-967


SEARCH JOBS

Adocia is a clinical-stage biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins. Adocia’s insulin formulation portfolio, featuring four clinical-stage products and one preclinical product, is among the largest and most differentiated in the industry.

YEAR FOUNDED:

December 2005

LEADERSHIP:

Founders: Gérard Soula, Olivier Soula, and Rémi Soula

CEO: Gérard Soula

CFO: Valérie Danaguezian

JOBS:

Please click here for Adocia job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.


Key Statistics


Email:
Ownership: Private

Web Site: Adocia
Employees:
Symbol: 
 



Industry
Biotechnology

Segment
Biotechnology





Company News
Adocia Received The EY Global Company Award For The Auvergne Rhône-Alpes Region 9/22/2016 11:22:11 AM
Adocia Announces New BioChaperone Program Combining A Basal Insulin And GLP-1s 9/14/2016 9:19:39 AM
Adocia To Present Clinical Data Validating BioChaperone Technology At The 2016 EASD Annual Meeting 9/8/2016 12:59:52 PM
Adocia Announces New BioChaperone Program Combining A Basal Insulin And GLP-1s 9/7/2016 2:30:00 PM
Adocia's Foot Ulcer Med Flunks Phase III Test 8/26/2016 6:48:25 AM
Adocia Reinforces Its Focus On Diabetes With The Launch Of A New Project: BioChaperone Glucagon 6/8/2016 1:01:05 PM
Adocia To Present Data Validating The Potential Of Biochaperone Technology At The American Diabetes Association 76th Scientific Sessions 6/6/2016 4:19:45 PM
Adocia And Eli Lilly (LLY) Announce Positive Topline Results From A Phase 1b Study Of Repeated Administration Of Ultra-Rapid Biochaperone Lispro U100 In People With Type 2 Diabetes 5/2/2016 1:17:18 PM
Adocia Announces First Quarter 2016 Results 4/14/2016 9:26:51 AM
Adocia Initiates A Phase 1/2 Clinical Trial On The Post-Meal Effect Of Rapid-Acting Human Insulin, HinsBet U100 4/12/2016 10:43:25 AM
123456
//-->